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OBJECTIVES The purpose of the study was to compare myocardial blood flow (MBF) in hyperlipidemic
postmenopausal women and age-matched hyperlipidemic men, and to analyze the relation-
ship between cholesterol subfractions and myocardial blood flow in men and women.
BACKGROUND Women are protected from coronary artery disease (CAD) events until well after menopause,
in part due to gender-specific differences in lipid profiles.
METHODS To examine the effect of these influences on coronary microcirculation, MBF was quantitated
with N-13 ammonia/PET (positron emission tomography) at rest and during adenosine
hyperemia in 15 women and 15 men, all nondiabetic, who were matched for age and total
cholesterol levels (53 6 4 vs. 50 6 8 years, p 5 NS, 6.44 6 1.1 vs. 6.31 6 0.85 mmol/liter,
or 249 6 41 vs. 244 6 33 mg/dl, p 5 NS).
RESULTS Women had significantly higher high density lipoprotein (HDL) and lower triglyceride (Tg)
levels than did men, and they showed significantly higher resting MBF and stress MBF levels.
Significant correlations were found between resting and hyperemic MBF and HDL and Tg
levels (r 5 0.44, p , 0.02 for stress MBF vs. HDL; r 5 0.48, p , 0.007 for stress MBF vs.
Tg). Gender was the strongest predictor of hyperemic MBF in multivariate analysis. Women
responded to adenosine hyperemia with a significantly higher heart rate than did men, and
hemodynamic factors correlated significantly with blood flow both at rest and during stress.
CONCLUSIONS These data suggest that the favorable lipid profile seen in women may be associated with
preserved maximal blood flow in the myocardium. (J Am Coll Cardiol 1999;33:463–70) ©
1999 by the American College of Cardiology
Elevated serum cholesterol is a well-established risk factor for
the subsequent development of coronary heart disease. Recent
studies have established that cholesterol-lowering therapy can
result in a decreased incidence of myocardial infarctions, and
an overall decrease in cardiovascular mortality both in the
primary and secondary prevention of coronary heart disease
(1,2). Part of this benefit appears to result from stabilization of
the coronary vascular endothelium, while relatively little regres-
sion of atherosclerotic plaque can be demonstrated (3). Several
investigators have demonstrated attenuated hyperemic myo-
cardial blood flow and coronary flow reserve, an integrating
parameter of endothelial function and vascular smooth muscle
relaxation, in male subjects with elevated cholesterol levels
prior to the angiographic appearance of coronary artery disease
(4,5). Although myocardial blood flow and flow reserve have
been studied in both men and women with respect to changes
observed during aging, no studies to date have systematically
examined myocardial blood flow and flow reserve in women
with risk factors for coronary artery disease (CAD) (6).
Women are known to be protected from CAD events until
after menopause, when the risk of myocardial infarction
increases sharply and begins to parallel the risk for men (7).
Part of this protective effect is felt to be due to higher levels of
high density lipoproteins (HDLs) and lower levels of low
density lipoproteins (LDLs), triglycerides (Tgs), and total
cholesterol in premenopausal women (8). The purpose of this
study, therefore, was to compare myocardial blood flow in
hyperlipidemic postmenopausal women with that of age-
matched hyperlipidemic men, and to analyze the relationship
between cholesterol subfractions and myocardial blood flow in
men and women.
METHODS
Study design and criteria. Fifteen postmenopausal women
with elevated total cholesterol levels and one or more
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additional risk factors for CAD were recruited for the study,
as were 15 asymptomatic men with hyperlipidemia and one
or more additional risk factors. Patient characteristics are
shown in Table 1. All men had undergone stress perfusion
imaging within 90 days of the PET (positron emission
tomography) study, and had normal studies. Three of the
women had symptoms of nonexertional chest pain; these
three patients had undergone cardiac catheterization and
had been shown to have normal coronary arteries. The
remaining 12 women were asymptomatic; in these patients,
normal semiquantitative PET studies were considered suf-
ficient to rule out epicardial coronary disease. Exclusion
criteria for all persons included diabetes mellitus and elec-
trocardiogram (ECG) evidence of myocardial infarction or
left ventricular hypertrophy.
All participants were fasting for at least 8 h, and caffeine
intake was stopped 24 h prior to the PET study. One
patient was on a long-acting theophylline preparation; this
was held for 72 h prior to the PET study. Blood samples for
determination of the lipoprotein status were obtained after
overnight fast just before the PET scan.
The study protocol was approved by the institutional
review boards of both the University of Michigan and the
Technical University of Munich. Each patient gave in-
formed consent prior to being enrolled into the study.
PET imaging protocol. N-13 ammonia was synthesized
by the 16O(p,a)13N reaction as described by Gelbard et al.
(9). Dynamic PET measurements were performed using a
whole-body PET-scanner (Siemens/ECAT 931, 951R/31,
Exact 47, or CTI 931), which allows simultaneous acquisi-
tion of 15 contiguous transaxial images. After placement in
the PET scanner, a “scout scan” was obtained to align the
heart within the field of view of the scanner using 74 MBq
N-13 ammonia. The patient’s position with respect to the
camera was checked by a cross-shaped, low-power laser
beam and pen markers on the patient’s skin. A 15-min
transmission scan was then acquired to correct for photon
attenuation using retractable germanium-68 ring sources.
After completion of the transmission scan, 740 MBq N-13
ammonia diluted in 10 cc of normal saline was administered
as a slow bolus over 30 s using a volumetric pump (Harvard
model 975, Harvard Apparatus, South Natick, MA) via a
peripheral intravenous (IV) line. At study onset, dynamic
scan acquisition was initiated with varying frame duration
(12 3 10 s/4 3 15 s/4 3 30 s/3 3 300 s). The total
scanning time was 20 min.
After acquisition of the baseline N-13 ammonia study, at
least 50 min was allowed for N-13 decay (physical half-life
9.9 min). During this time, residual N-13 activity from the
preceding scan had physically decayed to ,3% of its initial
activity.
For the stress study, myocardial blood flow was increased
by IV adenosine infused at 0.14 mg/kg/min over 5 min
using a Harvard pump. Heart rate and blood pressure were
monitored at 1-min intervals during the first 10 min of the
study, and at the conclusion of scanning. Mean blood
pressure (MBP) was calculated as (systolic blood pressure
12 3 diastolic blood pressure)/3. Pressure-rate product
(PRP) was calculated as heart rate multiplied by systolic
blood pressure. The ECG was continuously monitored.
Three minutes after the onset of the adenosine infusion,
N-13 ammonia was injected. The PET data acquisition
protocol was identical to the baseline study.
Image processing. Images were reconstructed using a
Hann filter with a cutoff frequency of 0.35. Slice thickness
for the 15 contiguous transaxial images was 6.75 mm,
resulting in an image resolution of 8.5 6 0.35 mm at
full-width at half maximum (FWHM) in-plane and 6.6 6
0.49 mm FWHM in the axial direction. The PET data
analysis was performed by one experienced observer who
evaluated all baseline rest/stress studies. Using a SUN
workstation (SUN Microsystems), 12 transaxial images
were created in the short-axis view of the heart. The vertical
and horizontal cardiac long-axis angles were defined using
the last frame of the N-13 ammonia dynamic sequence with
Abbreviations and Acronyms
CAD 5 coronary artery disease
HDL 5 high density lipoprotein
HR 5 heart rate
LAD 5 left anterior descending
LCx 5 left circumflex
LDL 5 low density lipoprotein
MBF 5 myocardial blood flow
MBP 5 mean blood pressure
MI 5 myocardial infarction
PET 5 positron emission tomography
PRP 5 pressure rate product
RCA 5 right coronary artery
SPECT 5 single photon emission computed tomography
Tg 5 triglyceride
Table 1. Patient Characteristics
Parameter
Women
(n 5 15)
Men
(n 5 15) p
Age (years) 53 6 4 50 6 8 0.19
TChol (mg/dl)* 249 6 41 244 6 33 0.71
LDL (mg/dl)* 162 6 52 170 6 32 0.58
HDL (mg/dl)* 72 6 19 39 6 9 , 0.001
Tg (mg/dl)* 114 6 63 181 6 59 0.01
TChol/HDL ratio 3.7 6 1.3 6.6 6 1.6 , 0.001
LDL/HDL ratio 2.5 6 1.2 4.6 6 1.1 0.0001
Smoking Hx 6 3 0.25
Htn 4 3 0.68
Family Hx 7 15 , 0.01
* To convert values to millimoles per liter, multiply by 0.02586.
TChol indicates total cholesterol; HDL, high density lipoprotein fraction; LDL,
low density lipoprotein fraction; Tg, triglycerides; Hx, history; Htn, hypertension
(systolic blood pressure .150, diastolic blood pressure .95, or current treatment for
hypertension). Values are given as mean 6 SD for continuous variables.
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the best tissue-to-blood ratio, and were subsequently used
for the reorientation of all 21 frames.
Quantification of myocardial blood flow. A previously
described method for automated region definition was used
for kinetic analysis of the acquired dynamic data set. Based
on radial activity profiles, the algorithm automatically de-
fines myocardial regions containing a blood volume fraction
of 50% to 60%. The algorithm incorporates corrections for
partial volume effects and blood-to-tissue cross-contamination
into the model equation (10).
Using the described algorithm, 12 myocardial regions per
plane were defined in 5 to 8 planes of the last time-frame
featuring a high contrast between blood and tissue. These
regions were subsequently copied to all remaining time-
frames of the dynamic sequence. Before time-activity curves
were generated, the dynamic image sequence was corrected
for patient motion as described previously (11). The dy-
namic image set was sampled, and time-activity curves were
generated in 12 myocardial sectors for each plane of the left
ventricle.
To assess the left ventricular blood pool time-activity
curve, a small circular region (diameter 3 pixels, approxi-
mately 9 mm) was drawn in two or three of the most basal
planes of the resliced image set and copied to the entire
serially acquired image sequence to obtain the arterial input
function (10). The time-activity curves were then fitted with
a previously validated three-compartment tracer kinetic
model (12).
In addition to calculating the myocardial blood flow
(MBF) for the left ventricle as a whole, MBF was deter-
mined for each of three vascular beds (left anterior descend-
ing [LAD], left circumflex [LCx], and right coronary artery
[RCA]). All PET studies were also analyzed semiquantita-
tively by comparison with a normal database, as previously
described (13).
Statistical analysis. Mean value and standard deviation
were calculated for each continuous variable. A two-tailed
Student t test for unpaired data sets was used to analyze for
statistical significance, with a p value less than 0.05 consid-
ered significant. McNemar’s test was used to analyze dif-
ferences between groups for categorical variables. Univariate
and multivariate stepwise linear regression analyses were
performed as described below to analyze the effects of each
variable on resting and stress blood flow. Univariate regres-
sion analysis was performed using Statview 4.1 for the
Macintosh (Abacus Concepts) with each risk factor sepa-
rately selected as the independent variable, analyzed against
MBF selected as the dependent variable. This analysis
provides an R value as well as a p value for significance, and
allows for the creation of a scattergram for graphic display of
results. Multivariate analysis was performed using Systat
5.2.1 for the Macintosh (Systat) to perform backward
stepwise regression analysis using the multivariate general
linear hypothesis function, with minimum tolerance for
entry into the model set at 0.01, and p value to enter as well
as to remove variables set at 0.15.
RESULTS
A total of 30 patients (15 men and 15 women) underwent
dynamic N-13 ammonia PET at rest and during adenosine-
induced hyperemia. The subjects were matched for age and
total cholesterol levels.
Baseline patient characteristics. Age, lipid profile values,
and presence of other risk factors for CAD are shown for
each group in Table 1. Significantly more men than women
had a family history of CAD, defined as myocardial infarc-
tion (MI) or revascularization before age 60 in a first-degree
relative; other risk factors were equivalent between the two
groups. Although the men and women had equivalent total
cholesterol and LDL levels, the women had significantly
higher HDL levels, and lower triglyceride (Tg) levels. In
addition, the total cholesterol/HDL and LDL/HDL ratios
were significantly lower for the women than for the men,
indicating more favorable lipid profiles for the women.
Hemodynamic findings. Table 2 summarizes the hemo-
dynamic characteristics at rest and during adenosine-
induced hyperemia for each group. There was no significant
difference in resting parameters between each group. During
hyperemia, both men and women showed a significant
increase in heart rate (HR), but only the women showed a
significant rise in PRP, owing to a greater average increase
in HR. There was no significant change in systolic, diastolic,
or MBP from rest to stress in either group. Patients in both
Table 2. Hemodynamic Findings
Parameter
Women (n 5 15) Men (n 5 15)
Rest Adenosine Rest Adenosine
Heart rate (bpm) 71 6 8 102 6 16* 69 6 11 79 6 41*
Systolic BP (mm Hg) 125 6 20 129 6 25 133 6 15 131 6 15
Diastolic BP (mm Hg) 80 6 15 80 6 14 80 6 11 76 6 9
Pressure Rate Product 8835 6 1708 13160 6 3257* 9180 6 2076 10401 6 2338†§
Mean BP (mm Hg) 95 6 15 96 6 16 98 6 11 95 6 10
* p , 0.05 vs. resting value. † p 5 NS vs. resting value. § p , 0.02 vs. women.
BP 5 blood pressure.
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groups experienced similar symptoms in response to aden-
osine: flushing, shortness of breath, headache, and chest
heaviness.
Visual and semiquantitative analysis of PET scans. One
patient in each group had evidence of a regional perfusion
abnormality by visual and semiquantitative analysis of PET
images. One woman had a small, fixed lateral wall defect
comprising less than 10% of the LCx vascular territory; this
patient had undergone coronary angiography and had been
shown to have normal coronary arteries, as well as normal
left ventricular function by contrast ventriculography. The
perfusion defect was not felt to be clinically relevant. Of the
men, one patient had a reversible inferoposterior perfusion
abnormality; however, the patient was asymptomatic and
had a normal exercise single photon emission computed
tomography (SPECT), and therefore coronary angiography
was not performed. It is possible that this patient had an
intermediate severity stenosis involving the right coronary or
LCx coronary artery.
Quantitative myocardial blood flow analysis. The MBF
values at rest and during adenosine-induced hyperemia are
shown in Figure 1. Resting MBF in female patients was
significantly higher than that of males. Blood flow in both
patient groups increased significantly during adenosine-
induced vasodilation (94 6 22 to 296 6 56 ml/100 g/min,
p , 0.0001 for women; 72 6 23 to 226 6 47 ml/100 g/min,
p , 0.0001 for men, Fig. 1). However, hyperemic MBF
remained significantly lower in the male group than in the
female group, as illustrated in Figure 1. Regional analysis of
resting and hyperemic MBF revealed similar variability
between vascular territories among men and women; there
was no difference between the coefficient of variance ob-
tained for the two groups for either resting or hyperemic
blood flow.
Correlaton of risk factors and myocardial blood flow.
None of the CAD risk factors documented in this patient
population (positive family history, smoking, and hyperten-
sion) was a significant predictor of diminished hyperemic
blood flow, and none correlated significantly with resting
flow measurements.
Correlation of lipids and myocardial blood flow. Both
total cholesterol level and lipid subfractions were compared
with resting blood flow and hyperemic myocardial blood
flow. The total cholesterol/HDL ratio and LDL/HDL
ratio were also compared. No significant correlation was
found between resting MBF and any lipid parameter,
although the correlation with HDL levels approached
statistical significance (r 5 0.32, p 5 0.09). As shown in
Figure 2, stress MBF showed significant correlations to
HDL level, Tg level, and cholesterol/HDL ratio. Hyper-
emic MBF showed the best correlation to Tg levels (r 5
0.48, p , 0.007). No significant correlations were detected
among total cholesterol levels, LDL levels, and LDL/HDL
ratio and resting or stress blood flow.
Comparison of MBF and hemodynamics. As shown in
Figure 3, both resting and hyperemic myocardial blood flow
values correlated significantly with the respective HR values
(r 5 0.50, p 5 0.005 for rest MBF; r 5 0.67, p , 0.0001 for
stress MBF). As a result of these HR correlations, MBF at rest
also correlated with resting PRP, while hyperemic MBF
correlated with stress PRP (r 5 0.56, p , 0.002 for rest MBF;
r 5 0.53, p , 0.002 for stress MBF). The pharmacological
effect of adenosine is reflected in the upward shift and steeper
slope of the hyperemic blood flow correlations compared with
correlations seen under resting conditions.
Multivariate linear regression. When all lipid parameters
as well as gender, age, CAD risk factors, and HR were
analyzed in multivariate fashion for their correlation to
resting and stress myocardial blood flow, resting HR was
the best predictor of resting MBF (p 5 0.003), although
HDL also remained a significant predictor (p 5 0.05). For
hyperemic MBF, gender was the strongest predictor (p 5
0.02), followed by HDL (p 5 0.03) and stress HR (p 5
0.04). The LDL level showed a trend toward significance as
a predictor of stress MBF (p 5 0.051).
DISCUSSION
We sought to compare noninvasively measured resting
and hyperemic myocardial blood flow (MBF) in a pop-
ulation of men and women of similar age, matched for
cardiovascular risk factors and total cholesterol levels.
Women differed from the men in that they had signifi-
cantly higher HDL levels, and significantly lower Tg
levels. The response to adenosine differed between men
and women, in that our female patients exhibited a more
marked heart rate (HR) response to adenosine. We found
that the group of 15 females showed significantly higher
resting as well as stress MBF than did their male
Figure 1. Myocardial blood flow (MBF) at rest and during
adenosine hyperemia is plotted for women vs. men. Both groups
show a significant rise in MBF during hyperemia, whereas values
for women are significantly higher both at rest and during
adenosine stress.
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counterparts, and that these findings correlated with the
lipid subfractions HDL and Tgs, which differed signifi-
cantly between the two groups. We also found significant
correlations between resting blood flow and HR as well as
pressure rate product (PRP) at rest, and between hyper-
emic blood flow and stress HR and PRP. We found no
differences in calculated myocardial flow reserve (stress
MBF/resting MBF) between men and women. Thus, our
study did not indicate that coronary vasodilator capacity
differs between men and women.
Lipid effects. To our knowledge, this is the first reported
comparison of myocardial blood flow responses between a
cohort of women and of men with risk factors for coronary
artery disease. Several differences became apparent when these
women were compared with a matched male population; some
Figure 2. Correlations between stress myocardial blood flow (MBF) and lipid parameters HDL, triglycerides, and cholesterol/HDL ratio
are plotted. Correlation coefficients and p values are as shown. To convert lipid values to millimoles per liter, multiply by 0.02586.
Figure 3. Correlations between myocardial blood flow (MBF) at rest and during stress and respective heart rate (HR) and pressure rate
product (PRP) are shown. Stress correlations are depicted by closed triangles for men and open triangles for women. Resting correlations
are depicted by closed circles for men and open circles for women. Correlation coefficients, p values, and equations for each correlation
are as shown.
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were expected, and others unexpected. It is well known that
women have a more favorable lipid profile in terms of risk
factors for CAD than do men; a significant part of the
observed gender gap in the heart disease prevalence between
women and men is believed to be due to these lipid factors
(14). Total cholesterol levels are believed to be as strong a
predictor of CAD risk in women as in men, but HDL level is
believed to be more closely correlated with CAD risk in
women than in men (8).
In addition, elevated triglycerides may be a significant
predictor of CAD risk in women to a greater extent than
they are in men (15). Elevated Tgs may cause altered
coronary blood flow on the basis of increased plasma
viscosity; they may also be a marker for insulin resistance
and thus for a predisposition to diabetes mellitus, which is
known to be associated with impaired MBF (16). Our
female population was postmenopausal; estrogen-
replacement therapy, which can prevent the decline in HDL
levels seen after menopause, and which may alter MBF, was
being taken by only one woman in the study group.
Sex differences have also recently been reported in plaque
morphology and the etiology of plaque rupture leading to
coronary thrombosis (17,18). These investigators found
that, whereas men most commonly developed thrombi due
to rupture of lipid-rich plaques, women more commonly
were found to develop intracoronary thrombi in areas of
endothelial erosion, which occurred over plaques composed
of smooth muscle cells and proteoglycans. Thus, the unfa-
vorable lipid profile more commonly seen in men may be
directly responsible for plaque vulnerability, whereas higher
HDL levels and lower Tg levels as more commonly found in
women may lead to alternate etiologies for coronary throm-
bosis, which presumably do not occur as frequently, and may
also not respond to lipid-lowering therapy in the same
manner (19).
Several recent studies have analyzed MBF using N-13
ammonia PET in a high-risk population (4,20). The find-
ings reported by Dayanikli et al. (4), whose patient popu-
lation consisted in part of the same patients used for the
current study, applied only to men, and showed diminished
hyperemic MBF and flow reserve in hypercholesterolemic
men with additional risk factors for CAD. Furthermore,
these investigators reported significant correlations among
coronary flow reserve and total cholesterol, LDL choles-
terol, and cholesterol/HDL ratio.
Yokoyama et al. (20) analyzed 14 men and 11 women
with familial hypercholesterolemia and again found that
both hyperemic myocardial blood flow and flow reserve
were diminished in these patients when compared with a
group of normal controls. They found statistically signifi-
cant correlations between flow reserve and total cholesterol
as well as LDL cholesterol levels. They also stratified both
the control group and the familial hypercholesterolemics by
gender, and showed higher stress MBF and flow reserve
both in the female controls and the female hyperlipidemic
patients; these differences were statistically significant only
for flow reserve between male and female hyperlipidemic
patients. The reasons for this difference remained largely
unexplained; however, no gender difference was noted in
their study in hemodynamic parameters or in lipid profiles.
Our study differs from these earlier reports in several
ways. First, we studied an age- and cholesterol-matched
group of women and men with additional risk factors for
coronary artery disease who did not meet criteria for familial
hyperlipidemia. Second, we found the expected gender
differences in HDL and Tg levels between our patient
groups, namely higher HDL and lower Tgs in women than
in men. Importantly, we were able to show significant
correlations between these lipid parameters and the hyper-
emic blood flow of the patients. Thus, we were able to
confirm the postulated interaction between coronary reac-
tivity and lipid levels seen by others (21).
Hemodynamic effects. Each group had equivalent resting
HR and blood pressure, resulting in a similar PRP at rest.
While both groups showed significant increases in HR
during adenosine-induced hyperemia, the women showed a
significantly greater rise in HR (D 5 31 for women vs. D 5
10 for men), resulting in a statistically significant increase in
PRP with stress only for the female study group. This
differential response could not be explained by heart-rate
slowing medications, as none of the men and only two of the
women were taking medications known to exert negative
chronotropic effects. Neither group showed any significant
change in blood pressure during adenosine hyperemia.
Previous studies undertaken to study hemodynamic re-
sponse to adenosine infusion have also shown a significant rise
in HR (22,23). However, in the face of maximal vasodilation,
HR should not be expected to further increase MBF. Aden-
osine was believed to exert vasodilatory effects independently of
its hemodynamic effects, which have been felt to be clinically
insignificant for the most part (22). A HR-mediated augmen-
tation of MBF has not been previously demonstrated. Indeed,
McGinn et al. (24) showed that hyperemic blood flow did not
change during pacing-induced increases in HR. We found that
resting MBF correlated significantly with the resting PRP and
resting HR, as has been shown by other investigators (6,24–
26). The resting MBF was significantly higher in women than
in men because of multiple factors. Although PRP was one
component that correlated linearly with MBF, other factors
including basal catecholamine levels, HDL levels, and HR
(both of which were a significant predictor of resting MBF in
multivariate analysis) also contributed to the resting blood flow.
However, we also noted a correlation between HR (and,
consequently, PRP) during adenosine-mediated vasodilation
and hyperemic blood flow, a finding not shown in previous
studies. This effect was entirely accounted for by the close
correlation noted between HR during hyperemia and blood
flow.
Analysis of our results shows that, while both HR and
PRP correlated with hyperemic blood flow, the pharmaco-
logical effect of adenosine was reflected by the upward shift
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and steeper slope of the hyperemic blood flow correlations
compared with correlations seen under resting conditions.
Dipyridamole acts as an indirect, and adenosine as a direct,
coronary vasodilator; both agents thereby uncouple blood
flow from oxygen demand and, consequently, from cardiac
work (27). Exogenous adenosine exerts vasodilatory effects
primarily on vascular smooth muscle cells, but it may also
reflect endothelium-dependent vasorelaxant effects because
hyperlipidemic patients presumably have impaired nitric
oxide release, and thus compensatory increased basal aden-
osine levels, which may lead to a reduction in responsiveness
to exogenous administration of the drug (28). Further interplay
between endothelium-dependent and -independent
adenosine-mediated effects can be related to the shear stress
caused by vasodilatation, which elicits nitric oxide release from
endothelial cells.
In the presence of impaired vasodilatory responses such as
can be seen in hyperlipidemic patients, this vasorelaxant effect
may be impaired (29). No studies have previously documented
a gender-related difference in hemodynamic response to aden-
osine, and others have found no significant relationship be-
tween hyperemic blood flow and HR or PRP (25,30). In fact,
because coronary blood flow occurs primarily during diastole,
an increase in HR may actually result in a decrease in MBF
because of reduced diastolic filling time. The increased HR
response noted in women serves as a marker in the current
study to support a differential pharmacologic effect of adeno-
sine in women compared with men.
Possible mechanisms for our observations include a rela-
tively greater catecholamine response to adenosine; percep-
tion of the infusion as a noxious stimulus could certainly
lead to a catecholamine surge, which could be expected to
exert several, potentially contradictory effects on MBF.
Stimulation of myocardial a1 and a2 receptors would lead
to coronary vasoconstriction and thus decrease MBF. How-
ever, stimulation of the relatively greater proportion of b1
and b2 receptors in the heart would lead to vasodilation and
a positive chronotropic effect. This increased HR would
lead to increased oxygen demand, and thus compensatory
increased MBF, if the adenosine-induced vasodilation were
less than complete. In a multicenter analysis of the safety
profile of adenosine stress, Cerqueira et al. (23) showed that
the risk of side effects during adenosine infusion was
increased in women compared with men. Thus, if women
experienced a differentially greater catecholamine surge in
response to adenosine infusion than men, they might have
an additional rise in MBF over and above the direct
vasodilatory effect of the drug.
Study limitations. Significantly more men than women had a
positive family history for CAD in our study population. This
well-established risk factor for CAD could have contributed to
the reduced stress MBF seen in the male cohort. However,
family history was not significantly correlated with impaired
hyperemic blood flow in our multivariate analysis. Our popu-
lation was otherwise well-matched in terms of commonly
accepted cardiovascular risk factors. Our patients did not
routinely undergo cardiac catheterization, and thus CAD could
not be absolutely ruled out in the majority of patients. How-
ever, any patient with symptoms that might be construed to be
cardiac in origin did undergo coronary angiography; these
patients were all found to have normal coronary arteries.
Furthermore, all male patients underwent exercise or pharma-
cologic stress in conjunction with SPECT imaging to exclude
significant disease, and PET images in all patients with the
exception of one man and one woman showed no perfusion
defects. Because rest-stress N-13 ammonia PET has been
shown to have a high diagnostic accuracy in excluding coronary
artery disease (31), coronary angiography was not believed to
be indicated.
Our finding that the HR response to adenosine differed
between men and women in the study most likely represents
an epiphenomenon, as the hemodynamic difference did not
account for the change in blood flow from rest to stress. To
define MBF responses in our population more completely,
these results should be compared with MBF measured in a
normal male and normal female population. However, it is
problematic to study women without risk factors for coro-
nary disease, for these women will often be of child-bearing
age, and will likely be unwilling to be subjected to unnec-
essary radiation exposure. Furthermore, these results do not
reflect purely endothelium-dependent effects. Unfortu-
nately, there currently is no single reliable noninvasive
method for studying endothelium-dependent vasodilata-
tion; use of the cold-pressor test is one possible modality
that could be considered, although its effects are quite
heterogeneous and difficult to standardize.
Conclusions. This study demonstrates gender differences in
noninvasively assessed myocardial blood flow at rest and during
hyperemia. Higher resting as well as hyperemic flow was
detected in women with risk factors for coronary artery disease
compared with age-matched men with similar risk-factor
profiles. Myocardial blood flow correlated significantly with
HDL levels and with Tg levels, and was also significantly
correlated to HR and to pressure rate product. These findings
may have implications for the use of adenosine hyperemia in
study populations of mixed gender. Analysis of a sex-specific
adenosine response requires further study; the potential role of
estrogen and progesterone should also be investigated. Our
findings support current pathophysiologic concepts that altered
lipid profiles contribute significantly to the risk of CAD, and
may provide additional insight into the delayed appearance of
CAD in women.
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